Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. - Wikidata - awgldk - TriplyDB

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

http://www.wikidata.org/entity/Q33926731

about

Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives Clinicopathological correlations in corticobasal degeneration The corticobasal syndrome-Alzheimer's disease conundrum Clinical profile of PiB-positive corticobasal syndrome Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications.Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.Visuoperception test predicts pathologic diagnosis of Alzheimer disease in corticobasal syndrome TDP-43 is a key player in the clinical features associated with Alzheimer's disease Imaging correlates of pathology in corticobasal syndrome.Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.Voxel-based meta-analysis of grey matter changes in Alzheimer's disease.Visual assessment of posterior atrophy development of a MRI rating scale.Presenting neuropsychological testing profile of autopsy-confirmed frontotemporal lobar degeneration Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study.Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment.TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.Cerebrospinal fluid volumetric MRI mapping as a simple measurement for evaluating brain atrophy.Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease.Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer's disease presenting as logopenic progressive aphasia.Staging TDP-43 pathology in Alzheimer's disease.The Role of the Left Anterior Temporal Lobe for Unpredictable and Complex Mappings in Word Reading.Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology.The paradox of syndromic diversity in Alzheimer disease.EFNS task force: the use of neuroimaging in the diagnosis of dementia.Atrophy in Alzheimer's Disease and Semantic Dementia: An ALE Meta-Analysis of Voxel-Based Morphometry Studies.Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.Early-Onset Alzheimer Disease.Clinicopathological correlations in behavioural variant frontotemporal dementia.Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.Clinical Aspects of Alzheimer's Disease.

P2860

Q22252525-11F4C0F5-237B-467A-8593-B830C92DDC69 Q28077809-6FD11D10-A9C7-49A8-8177-0F4F58CEA022 Q28245070-2EF6A108-76E0-414E-8938-E626FBF56001 Q28250881-45779C6A-AC8B-4D3A-8224-901AEB0D0699 Q28486042-7F5D6F88-4FA5-423A-8F6B-45CC602DC0AA Q33573072-F2F78969-484A-4D37-8FFE-BE147551A07C Q33854681-661CAE57-C5A8-46D3-AED5-7D6906CBEBF9 Q33992842-D19B9143-5B24-4F46-A224-1C9ACCFE49C2 Q34079332-3A9ADB58-ACE1-4821-A966-3AC912F1B34F Q34232167-B8364FD3-03EA-483E-A5C3-BB8BB0C9FCDE Q34370058-B183CC22-ECA6-44BD-B2C0-AAE8FD39521F Q34575415-E64E3AF8-BFFA-45FA-BCAF-CA658B38D449 Q35219292-3250CDD1-1AF4-4BAC-A81F-35BBB66D6FEC Q35234807-67252F46-E8B1-418D-9B41-613CB93B58E9 Q35237938-196BDDAF-7EB6-4BD6-97A2-823E9710613B Q35552599-BD81424C-E43F-4A88-A998-B2B34C572637 Q36025839-7E29BC5B-94F1-4C56-9E57-2E86EB39A205 Q36146037-AA2440DB-A244-441D-9880-4F8C77D24E0E Q36182245-187302EB-91B6-4130-AFEB-0C5809404283 Q36217832-B5A6F77E-10BD-421F-B082-21B37B644B6A Q36351574-694902EA-4744-49AC-B376-2330692484EF Q36353123-A5D6ABFB-F0C2-4DC7-ACE8-EF27CC97B2D5 Q36374857-DFC382C6-A87A-4EA1-ACD1-361427C8322E Q36577827-D653E1E6-AF64-43C2-B273-9163FFB4C57D Q36632494-28AAFE78-8775-421A-9C04-885A67DC2BC6 Q36724441-A0C7903F-CEAE-4938-A766-49ED32C8B3F4 Q36764239-5D936561-02C8-4652-8DC3-9299F05EE95C Q37228684-B19BEC10-AFAC-4AAB-8F86-1707C213548B Q37341600-54FD895B-6E39-4F93-BAD8-8391A00EF55C Q37621617-A5C23226-1990-41F9-B00C-D84703CC1663 Q37737628-1DE08349-C90B-4C4F-A957-B0B91EF71043 Q37980047-FFB6835D-BAFF-45E5-8BE7-835268BB59B7 Q38026786-C1C66548-D5B7-4FC3-B727-A2CA5DBB46B3 Q38035398-D2D03B9C-C931-4330-B16D-546E1B5133E2 Q38388339-FFE3A906-44F7-43D1-9C22-D428077EEAC0 Q38690632-2274847C-2CA6-4B90-AD52-D8797266CBF4 Q39243357-68232697-C1BE-4B5E-B2A0-F7AB5AF2F019 Q45952280-EBAE1F40-38F7-4104-9575-BA7AAB4333B1 Q46423062-EE7735A5-5F06-4880-B178-4ED4FCFC743A Q52089713-412EBCB0-46AA-4181-A2AD-D739E620E05D

P2860

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

http://www.wikidata.org/entity/Q33926731

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

@ast

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

@en

type

label

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

@ast

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

@en

prefLabel

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

@ast

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

@en

P1433

Q33926731-63445975-E008-4F77-93D5-EF07C87EA73E

P1476

Q33926731-B0DEA38A-C581-4265-B8CD-A6F4879ABB92

P2093

Q33926731-2121263B-6B0B-4430-95CC-C11C460C3CCC

Q33926731-265D24D4-07AB-4846-97E8-6C0E5A3BD14A

Q33926731-414C05B8-1DB4-4E3C-A19C-CBFC629E4D5B

Q33926731-95861599-1F21-4C40-8F42-DAB9F890BE20

Q33926731-BE578366-1D2D-45D7-BAB6-282B75054C69

P2860

Q33926731-05151F87-F1DD-48C8-8C5A-C3D6D8E3F44F

Q33926731-15CA850D-C4A1-46CF-A087-10B1337DABE7

Q33926731-1729C651-9EEB-4EE5-8B0D-3B188717728F

Q33926731-22F95040-C2DE-484B-97DE-C55AB8237A16

Q33926731-275D6D32-F08D-4F7A-9213-5E304F68221A

Q33926731-2ED630D3-B743-45D8-8FD4-CB93334599FD

Q33926731-30E218E4-67AE-455A-8F05-F9FD790D0151

Q33926731-3B7F497C-1BEF-467C-A624-953FEF290804

Q33926731-3F3E31B5-7D44-43C0-A6F3-E6DB384AED5F

Q33926731-4CD74DD3-7D95-44A2-A5F8-FFBE79A2FD82

P304

Q33926731-02B25633-8640-4F7C-AC62-C83D560A12C7

P31

Q33926731-75FD308D-C5A9-48BE-96DF-C86E4787EA99

P356

Q33926731-D6728350-39B0-4AC2-A95A-74B508E28788

P407

Q33926731-00E191B5-7CBC-4D7E-9396-AC7BF552A6CB

P433

Q33926731-DF9C2D61-EF34-4ED0-84BF-02137DC00F9E

P478

Q33926731-C22CC7B5-845A-413F-8679-8118500BC1A2

P50

Q33926731-06BAA737-9B08-43E1-AF7C-C9F30E9228AC

Q33926731-33E0AE34-7AEA-4EDD-ABC9-97035B5351EE

Q33926731-7E4B031B-33F1-4A9A-AB0F-F04B460A97F7

Q33926731-A8B3A6B5-8B11-43D2-A692-B25BA8A6889B

Q33926731-E070AACA-0746-43FF-B0E6-1736998DCDA2

P577

Q33926731-54DC3E3B-E307-47CA-88D9-D5E704CA8004

P5875

Q33926731-EAE24D28-EAAD-4E8C-8573-25428762A01E

P698

Q33926731-338DABB3-1047-4975-ABE1-62EEE182F554

P932

Q33926731-8CD16103-3B37-4402-9995-1901BF876CAD

P356

J.NEUROBIOLAGING.2009.10.012

P1433

Neurobiology of Aging

P1476

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

@en

P2093

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Jennifer L Whitwell

http://www.w3.org/2001/XMLSchema#string

Joseph E Parisi

http://www.w3.org/2001/XMLSchema#string

Keith A Josephs

http://www.w3.org/2001/XMLSchema#string

Scott A Przybelski

http://www.w3.org/2001/XMLSchema#string

P2860

Cognition and anatomy in three variants of primary progressive aphasia

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Voxel-based morphometry--the methods

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

Focal cortical presentations of Alzheimer's disease

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Unified segmentation

P304

1531-1541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2009.10.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Dennis W. Dickson

Matthew L Senjem

Ronald C. Petersen

David S Knopman

P577

2009-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38090707

http://www.w3.org/2001/XMLSchema#string

P698

19914744

http://www.w3.org/2001/XMLSchema#string

P932

2888989

http://www.w3.org/2001/XMLSchema#string